![No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs - ScienceDirect No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S037851732201033X-ga1.jpg)
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs - ScienceDirect
![Mean fine-particle dose (FPD) (A) and total emitted dose (TED) (B) of... | Download Scientific Diagram Mean fine-particle dose (FPD) (A) and total emitted dose (TED) (B) of... | Download Scientific Diagram](https://www.researchgate.net/publication/277779575/figure/fig1/AS:267439506194439@1440773955249/Mean-fine-particle-dose-FPD-A-and-total-emitted-dose-TED-B-of-budesonide-with-BF.png)
Mean fine-particle dose (FPD) (A) and total emitted dose (TED) (B) of... | Download Scientific Diagram
![PDF) Determination of Fine Particle Dose for Orally Inhaled Products (OIPs) by Abbreviated Impactor Methodologies: Results from a Multi-Centre Study on behalf of the Impactor Sub-Team of the European Pharmaceutical Aerosol Group ( PDF) Determination of Fine Particle Dose for Orally Inhaled Products (OIPs) by Abbreviated Impactor Methodologies: Results from a Multi-Centre Study on behalf of the Impactor Sub-Team of the European Pharmaceutical Aerosol Group (](https://www.researchgate.net/profile/Jolyon-Mitchell/publication/288838536/figure/tbl1/AS:669318173962257@1536589296702/Abbreviated-Impactor-Measurement-Apparatus-Descriptions_Q320.jpg)
PDF) Determination of Fine Particle Dose for Orally Inhaled Products (OIPs) by Abbreviated Impactor Methodologies: Results from a Multi-Centre Study on behalf of the Impactor Sub-Team of the European Pharmaceutical Aerosol Group (
![Fine Particle Profile of Fluticasone Propionate/Formoterol Fumarate Versus Other Combination Products: the DIFFUSE Study | SpringerLink Fine Particle Profile of Fluticasone Propionate/Formoterol Fumarate Versus Other Combination Products: the DIFFUSE Study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13556-013-0003-9/MediaObjects/13556_2013_3_Fig1_HTML.gif)
Fine Particle Profile of Fluticasone Propionate/Formoterol Fumarate Versus Other Combination Products: the DIFFUSE Study | SpringerLink
![Mechanisms of ultrafine particle-induced respiratory health effects | Experimental & Molecular Medicine Mechanisms of ultrafine particle-induced respiratory health effects | Experimental & Molecular Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs12276-020-0394-0/MediaObjects/12276_2020_394_Fig1_HTML.png)
Mechanisms of ultrafine particle-induced respiratory health effects | Experimental & Molecular Medicine
![Influence of physical properties of carrier on the performance of dry powder inhalers - ScienceDirect Influence of physical properties of carrier on the performance of dry powder inhalers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383515300629-gr3.jpg)
Influence of physical properties of carrier on the performance of dry powder inhalers - ScienceDirect
![Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes - ScienceDirect Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517321001459-gr4.jpg)
Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes - ScienceDirect
![Influence of physical properties of carrier on the performance of dry powder inhalers - ScienceDirect Influence of physical properties of carrier on the performance of dry powder inhalers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211383515300629-fx1.jpg)
Influence of physical properties of carrier on the performance of dry powder inhalers - ScienceDirect
![Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes - ScienceDirect Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517321001459-gr6.jpg)
Increasing the fine particle fraction of pressurised metered dose inhaler solutions with novel actuator shapes - ScienceDirect
![Improving Medication Adherence in COPD with an Effective Device Orapan Poachanukoon, MD. - ppt download Improving Medication Adherence in COPD with an Effective Device Orapan Poachanukoon, MD. - ppt download](https://images.slideplayer.com/19/5809831/slides/slide_27.jpg)
Improving Medication Adherence in COPD with an Effective Device Orapan Poachanukoon, MD. - ppt download
![Figure 4 from Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI) | Semantic Scholar Figure 4 from Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b61a00208404e6d53024c08ef1f0ec3964a401cb/7-Figure4-1.png)
Figure 4 from Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI) | Semantic Scholar
![Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks - Journal of Pharmaceutical Sciences Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/0330997c-7383-49f9-986f-ba980a901452/gr1_lrg.jpg)
Predicting the Fine Particle Fraction of Dry Powder Inhalers Using Artificial Neural Networks - Journal of Pharmaceutical Sciences
![Dry Powder Inhaler: Probing the Particulate Microstructure of the Aerodynamic Particle Size in Combination Products - pharma excipients Dry Powder Inhaler: Probing the Particulate Microstructure of the Aerodynamic Particle Size in Combination Products - pharma excipients](https://www.pharmaexcipients.com/wp-content/uploads/2018/08/table-with-results-of-single-particle-aerosol-mass-spectrometry-for-two-dry-powder-inhalers.jpg)
Dry Powder Inhaler: Probing the Particulate Microstructure of the Aerodynamic Particle Size in Combination Products - pharma excipients
An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug | PLOS ONE
![Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler](http://old.scielo.br/img/revistas/jbpneu/v38n6/en_a10fig02.jpg)
Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler
![What the pulmonary specialist should know about the new inhalation therapies | European Respiratory Society What the pulmonary specialist should know about the new inhalation therapies | European Respiratory Society](https://erj.ersjournals.com/content/erj/37/6/1308/F1.large.jpg)
What the pulmonary specialist should know about the new inhalation therapies | European Respiratory Society
![What the pulmonary specialist should know about the new inhalation therapies | European Respiratory Society What the pulmonary specialist should know about the new inhalation therapies | European Respiratory Society](https://erj.ersjournals.com/content/erj/37/6/1308/F2.large.jpg)
What the pulmonary specialist should know about the new inhalation therapies | European Respiratory Society
![Are extra-fine particles from dry powder inhalers likely to improve lung deposition? | European Respiratory Society Are extra-fine particles from dry powder inhalers likely to improve lung deposition? | European Respiratory Society](https://erj.ersjournals.com/content/erj/44/Suppl_58/P909/F1.large.jpg)